Michael Molyneaux
Chief Medical Officer.Â
pharmaceutical
Upstate Biotech?Accelerator
China
Biography
MD, MBA,Chief Medical Officer. Before joining the company, Dr. Molyneaux served as CMO of Marcrosure Ltd. (NASDAQ: MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds. He was a member of Management leadership team that participated in the IPO in 2014 and raised 55 million dollars. He completed his medical school and residency training at Dalhousie University in Nova Scotia, Canada and is board certified in both Canada and the United States. He also completed an MBA at Washington University in St. Louis, and a BSc, Biology at University Prince Edward Island in Prince Edward Island, Canada.
Research Interest
Pharmaceutical science
